Tepotinib in non-small cell lung cancer (NSCLC) with MET-exon 14 skipping mutations (METex14+) and MET amplification (METamp); A phase II trial in progress
作者
Paul K. Paik,Hiroshi Sakai,Rolf Bruns,Jürgen Scheele,J. Sträub,Enriqueta Felip
出处
期刊:Annals of Oncology [Elsevier BV] 日期:2018-11-01卷期号:29: ix169-ix169被引量:3